{
    "id": "professional_medicine-098",
    "question": "A 64-year-old man with non-Hodgkin lymphoma comes to the physician because of a 3-week history of progressive numbness in his hands and feet and weakness in his legs when he stands. He received his third course of chemotherapy 4 weeks ago. Physical examination shows areflexia. Which of the following drugs is the most likely cause of these adverse effects?",
    "options": {
        "A": "Doxorubicin",
        "B": "Fluorouracil",
        "C": "Methotrexate",
        "D": "Vincristine"
    },
    "answer": "D",
    "predict": "{\"step_by_step_thinking\": \"To determine the most likely cause of the patient's symptoms, let's analyze the information provided. The patient has non-Hodgkin lymphoma and has received his third course of chemotherapy 4 weeks ago. The symptoms include progressive numbness in his hands and feet, weakness in his legs when he stands, and areflexia (absence of reflexes). These symptoms are suggestive of peripheral neuropathy, which is a common side effect of certain chemotherapy agents. The patient's age and the fact that this is his third course of chemotherapy also increases the likelihood of peripheral neuropathy due to cumulative toxicity.\\n\\nPeripheral neuropathy is a dose-dependent and cumulative effect of certain chemotherapy agents, particularly those that affect the nervous system. The drugs listed in the options have different mechanisms of action and side effect profiles. Doxorubicin and fluorouracil are more commonly associated with cardiotoxicity and gastrointestinal toxicity, respectively. Methotrexate can cause myelosuppression, hepatotoxicity, and renal toxicity, but it is less commonly associated with peripheral neuropathy.\\n\\nVincristine, on the other hand, is a vinca alkaloid that works by inhibiting microtubule formation in the nervous system, leading to axonal degeneration and peripheral neuropathy. This is a well-known side effect of vincristine, and the patient's symptoms are consistent with this diagnosis. The patient's age and the fact that this is his third course of chemotherapy also supports this diagnosis, as cumulative toxicity from vincristine can lead to more severe side effects over time.\\n\\nTherefore, based on the patient's symptoms and the mechanism of action of the drugs listed, the most likely cause of the patient's adverse effects is vincristine.\"} \"answer_choice\": \"D\"",
    "snippets": [],
    "scores": [],
    "execution_time": 10.266985654830933
}